BG100154A - Carbazole derivatibes having inhibiting effect to 17,20-lyase - Google Patents
Carbazole derivatibes having inhibiting effect to 17,20-lyaseInfo
- Publication number
- BG100154A BG100154A BG100154A BG10015495A BG100154A BG 100154 A BG100154 A BG 100154A BG 100154 A BG100154 A BG 100154A BG 10015495 A BG10015495 A BG 10015495A BG 100154 A BG100154 A BG 100154A
- Authority
- BG
- Bulgaria
- Prior art keywords
- group
- derivatibes
- lyase
- carbazole
- mean
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310635A GB9310635D0 (en) | 1993-05-21 | 1993-05-21 | Chemical compounds |
| PCT/EP1994/001613 WO1994027989A1 (fr) | 1993-05-21 | 1994-05-19 | Derives de carbazole a activite d'inhibition de 17,20-lyase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG100154A true BG100154A (en) | 1996-07-31 |
Family
ID=10736007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG100154A BG100154A (en) | 1993-05-21 | 1995-11-21 | Carbazole derivatibes having inhibiting effect to 17,20-lyase |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0699196A1 (fr) |
| JP (1) | JPH08510455A (fr) |
| CN (1) | CN1126473A (fr) |
| AU (1) | AU6928794A (fr) |
| BG (1) | BG100154A (fr) |
| CA (1) | CA2162921A1 (fr) |
| CZ (1) | CZ305195A3 (fr) |
| FI (1) | FI955587A0 (fr) |
| GB (1) | GB9310635D0 (fr) |
| HU (1) | HUT73790A (fr) |
| IL (1) | IL109703A0 (fr) |
| NO (1) | NO954681D0 (fr) |
| OA (1) | OA10195A (fr) |
| PE (1) | PE31195A1 (fr) |
| PL (1) | PL311702A1 (fr) |
| SK (1) | SK142495A3 (fr) |
| TW (1) | TW279866B (fr) |
| WO (1) | WO1994027989A1 (fr) |
| ZA (1) | ZA943494B (fr) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2170874A1 (fr) * | 1993-09-30 | 1995-04-06 | Minoru Okada | Derive d'azole et composition pharmaceutique le contenant |
| WO1996014090A1 (fr) * | 1994-11-07 | 1996-05-17 | Janssen Pharmaceutica N.V. | Compositions comprenant des carbazoles et des cyclodextrines |
| WO1996026927A1 (fr) * | 1995-03-01 | 1996-09-06 | Yamanouchi Pharmaceutical Co., Ltd. | Derives d'imidazole et composition medicinale a base desdits derives |
| WO1998037070A1 (fr) * | 1997-02-21 | 1998-08-27 | Takeda Chemical Industries, Ltd. | Composes a anneaux condenses, leur procede de production et leur utilisation |
| MY134929A (en) | 2000-11-17 | 2008-01-31 | Takeda Pharmaceutical | Novel imidazole derivatives, production method thereof and use thereof |
| EP1344777B1 (fr) | 2000-11-20 | 2011-03-16 | Takeda Pharmaceutical Company Limited | Derives de l'imidazole, leur procede de preparation et leur application |
| EP1348706B1 (fr) | 2000-12-08 | 2009-08-19 | Takeda Pharmaceutical Company Limited | Derives thiazole substitues porteurs de groupes 3-pyridyl, procede d'elaboration et leur utilisation |
| BRPI0611705A2 (pt) * | 2005-06-24 | 2016-11-16 | Lilly Co Eli | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de composto |
| GB0525323D0 (en) | 2005-12-13 | 2006-01-18 | Sterix Ltd | Compound |
| US8093279B2 (en) | 2005-12-13 | 2012-01-10 | Gillian Reed, legal representative | Compound |
| CN100586932C (zh) * | 2007-01-26 | 2010-02-03 | 中国医学科学院医药生物技术研究所 | 抗肿瘤化合物及其制备方法 |
| DK2445903T3 (da) | 2009-06-26 | 2014-06-23 | Novartis Ag | 1,3-Disubstituerede imidazolidin-2-on-derivater som CYP17-inhibitorer |
| EP2531029B1 (fr) * | 2010-02-04 | 2016-10-19 | Radius Health, Inc. | Modulateurs sélectifs du récepteur des androgènes |
| ME02474B (fr) | 2010-05-12 | 2017-02-20 | Radius Health Inc | Schémas thérapeutiques |
| KR101594660B1 (ko) | 2010-08-04 | 2016-02-16 | 펠피큐어 파마슈티걸즈 아이엔씨 | 전립선 암종의 치료를 위한 병용 요법 |
| WO2012035078A1 (fr) | 2010-09-16 | 2012-03-22 | Novartis Ag | Inhibiteurs de la 17α-hydroxylase/c17,20-lyase |
| BR112013007685B1 (pt) | 2010-09-28 | 2021-11-09 | Radius Pharmaceuticals, Inc | Compostos moduladores de receptor andrógeno seletivos, composição farmacêutica compreendendo os referidos compostos, método de identificação de um composto capaz de modular um receptor andrógeno, usos de um composto ou da composição e processo para a preparação de um composto |
| CN103649073B (zh) | 2011-04-28 | 2016-04-13 | 诺瓦提斯公司 | 17α-羟化酶/C17,20-裂合酶抑制剂 |
| US9492460B2 (en) * | 2013-02-27 | 2016-11-15 | Bristol-Myers Squibb Company | Carbazole compounds useful as bromodomain inhibitors |
| US20160022606A1 (en) | 2013-03-14 | 2016-01-28 | Pellficure Pharmaceuticals Inc. | Novel therapy for prostate carcinoma |
| EP4035664A3 (fr) | 2014-03-28 | 2022-11-30 | Duke University | Traitement du cancer faisant intervenir des modulateurs sélectifs des récepteurs des strogènes |
| US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
| WO2016040896A1 (fr) | 2014-09-12 | 2016-03-17 | Pellficure Pharmaceuticals, Inc. | Compositions et méthodes de traitement d'un carcinome de la prostate |
| RU2769527C2 (ru) | 2016-06-22 | 2022-04-01 | Эллипсес Фарма Лтд | Способы лечения ar+ рака молочной железы |
| CA3044812A1 (fr) | 2016-10-24 | 2018-05-03 | Pellficure Pharmaceuticals Inc. | Compositions pharmaceutiques de 5-hydroxy-2-methylnaphtalene-1, 4-dione |
| KR102322802B1 (ko) | 2017-01-05 | 2021-11-04 | 래디어스 파마슈티컬스, 인코포레이티드 | Rad1901-2hcl의 다형 형태 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS229934B2 (en) * | 1981-07-07 | 1984-07-16 | Pfizer | Production method subst.indolylacryte acid derivative |
| GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
-
1993
- 1993-05-21 GB GB939310635A patent/GB9310635D0/en active Pending
-
1994
- 1994-05-02 ZA ZA943494A patent/ZA943494B/xx unknown
- 1994-05-17 TW TW083104441A patent/TW279866B/zh active
- 1994-05-19 SK SK1424-95A patent/SK142495A3/sk unknown
- 1994-05-19 AU AU69287/94A patent/AU6928794A/en not_active Abandoned
- 1994-05-19 WO PCT/EP1994/001613 patent/WO1994027989A1/fr not_active Application Discontinuation
- 1994-05-19 HU HU9503321A patent/HUT73790A/hu unknown
- 1994-05-19 CZ CZ953051A patent/CZ305195A3/cs unknown
- 1994-05-19 CN CN94192683A patent/CN1126473A/zh active Pending
- 1994-05-19 PL PL94311702A patent/PL311702A1/xx unknown
- 1994-05-19 CA CA002162921A patent/CA2162921A1/fr not_active Abandoned
- 1994-05-19 EP EP94917647A patent/EP0699196A1/fr not_active Withdrawn
- 1994-05-19 JP JP7500181A patent/JPH08510455A/ja active Pending
- 1994-05-20 IL IL10970394A patent/IL109703A0/xx unknown
- 1994-11-18 PE PE1994255110A patent/PE31195A1/es not_active Application Discontinuation
-
1995
- 1995-11-17 OA OA60742A patent/OA10195A/en unknown
- 1995-11-20 NO NO954681A patent/NO954681D0/no unknown
- 1995-11-20 FI FI955587A patent/FI955587A0/fi not_active Application Discontinuation
- 1995-11-21 BG BG100154A patent/BG100154A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH08510455A (ja) | 1996-11-05 |
| PL311702A1 (en) | 1996-03-04 |
| NO954681L (no) | 1995-11-20 |
| EP0699196A1 (fr) | 1996-03-06 |
| TW279866B (fr) | 1996-07-01 |
| AU6928794A (en) | 1994-12-20 |
| IL109703A0 (en) | 1994-08-26 |
| OA10195A (en) | 1996-12-18 |
| GB9310635D0 (en) | 1993-07-07 |
| FI955587A (fi) | 1995-11-20 |
| HUT73790A (en) | 1996-09-30 |
| NO954681D0 (no) | 1995-11-20 |
| CN1126473A (zh) | 1996-07-10 |
| ZA943494B (en) | 1995-01-23 |
| CA2162921A1 (fr) | 1994-12-08 |
| PE31195A1 (es) | 1995-10-18 |
| WO1994027989A1 (fr) | 1994-12-08 |
| HU9503321D0 (en) | 1996-01-29 |
| CZ305195A3 (en) | 1996-06-12 |
| SK142495A3 (en) | 1996-06-05 |
| FI955587A0 (fi) | 1995-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG100154A (en) | Carbazole derivatibes having inhibiting effect to 17,20-lyase | |
| TW358808B (en) | Morpholine derivatives, preparation thereof and pharmaceutical composition containing the same | |
| TW369526B (en) | Diazabicyclic neurokinin antagonists | |
| PH23739A (en) | Piperidine derivative and pharmaceutical composition | |
| UA41251C2 (uk) | Гідровані азотвмісні гетероциклічні сполуки, похідні піперидину, фармацевтична композиція та спосіб пригнічення активності речовини р в організмі | |
| HU895609D0 (en) | Process for the preparation of novel 1,4-diazepine derivatives and pharmaceutical compositions containing such compounds | |
| ES8303411A1 (es) | Un procedimiento para la preparacion de derivados de tiofilina o teobromina. | |
| IL108259A0 (en) | Piperazine derivates, their preparation and pharmaceutical compositions containing them | |
| NZ214787A (en) | Arylcyclobutylalkylamines and pharmaceutical compositions | |
| ES8200679A1 (es) | Un procedimiento para la preparacion de derivados de carboestirilo. | |
| ES2000481A6 (es) | Procecimiento de preparacion de nuevos derivados del dihidro-2,3 benzofurano | |
| ES8506629A1 (es) | Un procedimiento para preparar derivados de piridina | |
| NZ208954A (en) | 1,4-dihydropyridine derivatives and pharmaceutical compositions | |
| ES8507090A1 (es) | Procedimiento para la obtencion de nuevas 1, 5-benzotiacepinas | |
| ES2019163A6 (es) | Procedimiento para preparar derivados de imidazol. | |
| ES8203867A1 (es) | Procedimiento para la obtencion de derivados de benzotiazol | |
| ES8801637A1 (es) | Un procedimiento para la preparacion de benzimidazoles. | |
| IL115085A (en) | Piperazine bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them | |
| TW333525B (en) | New perhydroisoindole derivatives, their preparation and the pharmaceutical compositions which contain them the invention relates to perhydroisoindole derivatives of general formula (I), and their salts when they exist advantageously as neurokinin A antagonists. | |
| ES8406442A1 (es) | Un procedimiento para preparar compuestos de acido quinolilacetico | |
| ES8105981A1 (es) | Procedimiento para la preparacion de derivados de 4-(nafta- leniloxi)piperidina | |
| IL92646A0 (en) | Imidazolyl and pyridyl derivatives of phenyl substituted 1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them | |
| ES8505345A1 (es) | Un procedimiento para la preparacion de nuevos derivados de aminoeticpiridina o pirazina. | |
| ES2009553A6 (es) | Procedimiento de preparacion de nuevos derivados del acido 2-(2,3-dihidrido-2-oxo-3-benzofuranil)-acetico. | |
| GB1080496A (en) | Improvements in or relating to a new derivatives of 2,4,6-triiodo-3-hydroxy-benzene and process for preparing the same |